Company news

aap Implantate AG news in 2025

aap Implantate AG's news releases, calls and decks from 2025, newest first.

View company

Aap Implantate AG: Cash capital increase

December 4, 2025

Aap Implantate AG reports strong growth in Q3/2025: +15%

October 28, 2025

Aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year

September 19, 2025

Aap Implantate AG closes the first half of the year with sales of € 6.2 million; clinical trial nears positive conclusion

September 16, 2025

Aap successfully completes human clinical trial for antibacterial surface technology

September 9, 2025

Aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements

August 1, 2025

Aap Implantate AG publishes final audited consolidated financial statements 2024 - confirmation of strong operational improvement

July 21, 2025

Aap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment

June 30, 2025

Aap Implantate AG: Company EBITDA for fiscal year 2024 at EUR –0.85 million; postponement of publication of consolidated financial statements

June 27, 2025

Aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region

May 6, 2025

Aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024

April 29, 2025

Announcement of an audit order by BaFin

April 11, 2025

Decks in 2025